{
    "clinical_study": {
        "@rank": "3225", 
        "arm_group": [
            {
                "arm_group_label": "Fostimon\u00ae", 
                "arm_group_type": "Experimental", 
                "description": "75 IU/vial, powder and solvent for solution for subcutaneous injection (Follicle Stimulating Hormone,IBSA Institut Biochimique SA)"
            }, 
            {
                "arm_group_label": "Gonal-F\u00ae", 
                "arm_group_type": "Active Comparator", 
                "description": "75 IU/vial powder and solvent for solution for subcutaneous injection (Follicle Stimulating Hormone; Merck Serono)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the non-inferiority study is to evaluate the clinical efficacy and the safety\n      of two different subcutaneous FSH preparations (Fostimon versus Gonal-F) for controlled\n      ovarian hyperstimulation in a GnRH-antagonist cycle."
        }, 
        "brief_title": "FSH in GnRH-antagonist Controlled Ovarian Hyperstimulation Cycles", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Ovarian Hyperstimulation Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 18-38 years old;\n\n          -  BMI: 18-28 kg/m2;\n\n          -  Less than 3 previously completed IVF cycles;\n\n          -  Basal FSH <10 IU/L and E2 <80 pg/ml;\n\n          -  TSH < 2.5 mIU/L\n\n          -  >10 antral follicles 2-10 mm in size for both ovaries combined\n\n          -  AMH: >1 ng/ml (7.15 pmol/l) and <4 ng/ml (28.6 pmol/l)\n\n          -  Presence and adequate visualization of both ovaries;\n\n          -  Within 12 months of the beginning of the study, uterine cavity consistent with\n             expected normal function as assessed through transvaginal ultrasound,\n             hysterosalpingogram, sonohysterogram or hysteroscopic examination;\n\n        Exclusion Criteria:\n\n          -  Primary ovarian failure or women known as poor responders;\n\n          -  PCO and PCOS;\n\n          -  Severe OHSS in a previous COH cycle;\n\n          -  Uterine malformation that may impair the possibility to get pregnant;\n\n          -  Ovarian cysts >10 mm;\n\n          -  Hydrosalpinx that have not been surgically removed or ligated;\n\n          -  Endometriosis stage 3 or 4;\n\n          -  Oocyte donation;\n\n          -  Severe male factor;\n\n          -  Pathologies associated with any contraindication of being pregnant;\n\n          -  History of recurrent miscarriage (more than 3 previous miscarriages);\n\n          -  Hypersensitivity to the study medication;\n\n          -  Abnormal bleeding of undetermined origin;\n\n          -  Uncontrolled thyroid or adrenal dysfunction;\n\n          -  Neoplasias;\n\n          -  Severe impairment of renal and/or hepatic function."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "38 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "720", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01969201", 
            "org_study_id": "13EU/FSH01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fostimon\u00ae", 
                "intervention_name": "Urofollitrophin", 
                "intervention_type": "Drug", 
                "other_name": "human derived follicle stimulation hormone"
            }, 
            {
                "arm_group_label": "Gonal-F\u00ae", 
                "intervention_name": "Follitrophin alpha", 
                "intervention_type": "Drug", 
                "other_name": "Recombinant follicle stimulation hormone"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Hormones", 
                "Follicle Stimulating Hormone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "In vitro fertilization (IVF)", 
            "Assisted reproduction technologies (ART)", 
            "GnRH-antagonist", 
            "Follicle stimulating hormone (FSH)"
        ], 
        "lastchanged_date": "April 2, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Christophe Blockeel"
                }, 
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium"
                    }, 
                    "name": "Universitair Ziekenhuis Brussel"
                }, 
                "investigator": {
                    "last_name": "Christophe Blockeel, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christine Wyns, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium"
                    }, 
                    "name": "UCL- Cliniques Universitaires Saint Luc"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Umberto Omodei"
                }, 
                "facility": {
                    "address": {
                        "city": "Brescia", 
                        "country": "Italy"
                    }, 
                    "name": "Spedali Civili di Brescia"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Edgardo Somigliana"
                }, 
                "facility": {
                    "address": {
                        "city": "Milan", 
                        "country": "Italy"
                    }, 
                    "name": "Fondazione Ca'Granda, Osp Maggiore Policlinico"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Massimo Candiani"
                }, 
                "facility": {
                    "address": {
                        "city": "Milan", 
                        "country": "Italy"
                    }, 
                    "name": "IRCCS San Raffaele"
                }, 
                "investigator": {
                    "last_name": "Enrico Papaleo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giuseppe De Placido"
                }, 
                "facility": {
                    "address": {
                        "city": "Naples", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 degli Studi di Napoli 'Federico II'"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giovanni Battista La Sala"
                }, 
                "facility": {
                    "address": {
                        "city": "Reggio Emilia", 
                        "country": "Italy"
                    }, 
                    "name": "Azienda Ospedaliera Di Reggio Emilia"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Manuel Munoz"
                }, 
                "facility": {
                    "address": {
                        "city": "Alicante", 
                        "country": "Spain", 
                        "zip": "03015"
                    }, 
                    "name": "Clinica IVI Alicante"
                }, 
                "investigator": {
                    "last_name": "Manuel Munoz, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Pedro Barri, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "8028"
                    }, 
                    "name": "Institut Universitari Dexeus"
                }, 
                "investigator": {
                    "last_name": "Pedro Barri, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Victoria Verd\u00f9"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Ginefiv Cl\u00ednica de Fertilidad"
                }, 
                "investigator": {
                    "last_name": "Victoria Verd\u00f9, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Cinzia Caligara"
                }, 
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "40011"
                    }, 
                    "name": "Instituto Valenciano de Infertilidad (IVI)"
                }, 
                "investigator": {
                    "last_name": "Cinzia Caligara, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Micheal von Wolf"
                }, 
                "facility": {
                    "address": {
                        "city": "Bern", 
                        "country": "Switzerland", 
                        "state": "Be"
                    }, 
                    "name": "Universit\u00e4tsklinik f\u00fcr Frauenheilkunde"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christian De Geyter"
                }, 
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "state": "BS"
                    }, 
                    "name": "Universit\u00e4ts-Frauenklinik"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ata Baris, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bursa", 
                        "country": "Turkey"
                    }, 
                    "name": "Uludag University"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Erol Tavmergen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Izmir", 
                        "country": "Turkey"
                    }, 
                    "name": "Ege University"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gillian Lockwood"
                }, 
                "facility": {
                    "address": {
                        "city": "Aldridge", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Midland Fertility Services"
                }, 
                "investigator": {
                    "last_name": "Gillian Lockwood, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Italy", 
                "Spain", 
                "Switzerland", 
                "Turkey", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomised Clinical Trial Comparing Highly Purified FSH Formulation (Fostimon\u00ae) and Recombinant FSH (Gonal-F\u00ae) in GnRH-antagonist Controlled Ovarian Hyperstimulation Cycles.", 
        "overall_contact": {
            "email": "barbara.cometti@ibsa.ch", 
            "last_name": "Barbara PS Cometti, PHD"
        }, 
        "overall_official": [
            {
                "affiliation": "Institut Universitari Dexeus, Barcelona, Spain", 
                "last_name": "Pedro Barri, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Universitair Ziekenhuis Brussel, Belgium", 
                "last_name": "Christophe Blockeel, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Italy: The Italian Medicines Agency", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Spain: Spanish Agency of Medicines", 
                "Switzerland: Swissmedic", 
                "Turkey: Ministry of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A clinical pregnancy is defined as a pregnancy showing ultrasound embryonic heart activity at 8 weeks of gestation;", 
            "measure": "Clinical pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01969201"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of follicles >16 mm on the day of hCG injection", 
                "safety_issue": "No", 
                "time_frame": "10-15 days after starting FSH stimulation"
            }, 
            {
                "measure": "Total number of oocytes retrieved", 
                "safety_issue": "No", 
                "time_frame": "2-3 weeks"
            }, 
            {
                "measure": "Fertilization rate", 
                "safety_issue": "No", 
                "time_frame": "2-3 weeks"
            }, 
            {
                "description": "Quality of the embryos will be evaluated just before embryo transfer on Day 3.", 
                "measure": "Embryo quality", 
                "safety_issue": "No", 
                "time_frame": "On culture day 3"
            }, 
            {
                "description": "Two weeks after embryo transfer, a serum pregnancy test will be performed.", 
                "measure": "Positive serum pregnancy test", 
                "safety_issue": "No", 
                "time_frame": "2 weeks after embryo transfer"
            }, 
            {
                "measure": "Delivery rate", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "description": "Patients who will not get pregnant during the study, will be allowed to perform a frozen embryo transfer. Cumulative pregnancy rate will include also pregnancies achieved after a frozen embryo transfer.", 
                "measure": "Cumulative pregnancy rate", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "IBSA Institut Biochimique SA", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "IBSA Institut Biochimique SA", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}